Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer

Marie-Christine W. Gast, Marc Zapatka, Harm van Tinteren, Marijke Bontenbal, Paul N. Span, Vivianne C. G. Tjan-Heijnen, Jaco C. Knol, Connie R. Jimenez, Jan H. M. Schellens, Jos H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1773-1783
JournalJournal of Cancer Research and Clinical Oncology
Volume137
Issue number12
DOIs
Publication statusPublished - Dec 2011

Keywords

  • Breast cancer
  • Recurrence-free survival
  • Prognostic markers
  • Serum
  • Anion-exchange fractionation
  • SELDI-TOF MS

Cite this

Gast, M-C. W., Zapatka, M., van Tinteren, H., Bontenbal, M., Span, P. N., Tjan-Heijnen, V. C. G., Knol, J. C., Jimenez, C. R., Schellens, J. H. M., & Beijnen, J. H. (2011). Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer. Journal of Cancer Research and Clinical Oncology, 137(12), 1773-1783. https://doi.org/10.1007/s00432-011-1055-4